Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
Clinical trial NCT00016263 · COMPLETED
Trial details
- NCT number
- NCT00016263
- Sponsor
- Genta Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.